European Parliament And Council Of EU "Not Far Apart" On Scrutiny Of High-Risk Devices, IVDs
This article was originally published in SRA
The provision relating to the scrutiny of high-risk products under the proposed EU regulations on medical devices and IVDs has at last made it onto the agenda of the joint talks between the European Parliament, Council of the European Union and the European Commission which were held on December 3.
You may also be interested in...
How do notified bodies ensure that their personnel, and the teams they allocate for conformity assessment of medical devices, have the precise knowledge and expertise needed? A new EU document gives guidance on this.
Only just over a month ago there were fears that the implementation of the EU Medical Device Regulation was going to be hampered by a lack of expert panel applicants. Now it seems there is no shortage. The news raises lots of questions about when and how the structure will now work.
The European Commission’s announcement of a lengthy delay to the Eudamed database launch date has generally been met with dismay, with member states challenging the decision. Now there is news of a concession.